WENDY CHEUNG: Open Payments
NPI 1922649318 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 28 payments from 10 companies in 2025. Trend: 2023 $878 · 2024 $563 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $171 |
| Galderma Laboratories, L.P. | 5 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Organon LLC | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| ConvaTec Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Botanix SB Inc | 1 | $18 |
| Celgene Corporation | 1 | $17 |
| REVANCE THERAPEUTICS, INC. | 1 | $16 |
Products named: DUPIXENT, Sotyktu, NEMLUVIO, INNOVAMATRIX AC, RINVOQ, Winlevi, LIBTAYO, SOFDRA.
Industry payments across NJ — which companies pay providers there.
